BACKGROUND: Due to uncertain evidence, lumbar fusion for degenerative indications is associated with the greatest measured practice variation of any surgical procedure. OBJECTIVE: To summarize the current evidence on the comparative safety and efficacy of lumbar fusion, decompression-alone, or nonoperative care for degenerative indications. METHODS: A systematic review was conducted using PubMed, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (up to June 30, 2016). Comparative studies reporting validated measures of safety or efficacy were included. Treatment effects were calculated through DerSimonian and Laird random effects models. RESULTS: The literature search yielded 65 studies (19 randomized controlled trials, 16 prospective cohort studies, 15 retrospective cohort studies, and 15 registries) enrolling a total of 302 620 patients. Disability, pain, and patient satisfaction following fusion, decompression-alone, or nonoperative care were dependent on surgical indications and study methodology. Relative to decompression-alone, the risk of reoperation following fusion was increased for spinal stenosis (relative risk [RR] 1.17, 95% confidence interval [CI] 1.06-1.28) and decreased for spondylolisthesis (RR 0.75, 95% CI 0.68-0.83). Among patients with spinal stenosis, complications were more frequent following fusion (RR 1.87, 95% CI 1.18-2.96). Mortality was not significantly associated with any treatment modality. CONCLUSION: Positive clinical change was greatest in patients undergoing fusion for spondylolisthesis while complications and the risk of reoperation limited the benefit of fusion for spinal stenosis. The relative safety and efficacy of fusion for chronic low back pain suggests careful patient selection is required (PROSPERO International Prospective Register of Systematic Reviews number, CRD42015020153).
S
urgical fusion has become one of the most commonly performed procedures for degenerative disease of the lumbar spine. [1] [2] [3] Over the past decade, the incidence of lumbar fusion for degenerative indications has more than doubled from 7.5 per 100 000 in 2000 to 17.8 per 100 000 in 2009. 3, 4 Rising rates of fusion have been accompanied by cost per case increases from $24 676 to $81 960 over the same ABBREVIATIONS: CI, confidence interval; LBP, low back pain; OR, odds ratio; RCT, randomized controlled trial; RR, relative risk; VAS, visual analog scale; WMD, weighted mean difference Supplemental digital content is available for this article at www.neurosurgery-online.com.
interval. 4 As a consequence of both escalating rates and costs, the total annual direct expense of fusion in the United States has risen nearly 8-fold to $33.9 billion. 4 The increasingly frequent use of lumbar fusion is complicated by widely varying surgical indications with regional rates differing by up to 20-fold, the greatest measured practice variation of any surgical procedure. 5, 6 Uncertainty resulting from limited scientific evidence contributes to the observed variation in clinical decision making. [5] [6] [7] While the overuse of lumbar fusion may result in undue complications and the misallocation of resources, decompression-alone or nonoperative care for degenerative indications may risk progressive spinal instability, intractable pain, and neurological impairment. 2, 8 In the absence of reliable estimates of the relative risks and benefits of lumbar fusion for degenerative indications, considerable variation in the use of fusion is expected to continue. 5 To improve the quality of patient care and identify methodologic causes of disparate findings, the relative safety and efficacy of fusion, decompression-alone, and nonoperative care for degenerative disease of the lumbar spine was evaluated through a systematic review and meta-analysis.
METHODS
This systematic review complies with relevant standards and was registered with the PROSPERO International Prospective Register of Systematic Reviews on April 30 2015 (updated July 5, 2016; CRD42015020153).
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Search Strategy
A search of PubMed, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials was performed for human studies without language or date restriction (see Table for 
Study Selection
As randomization may not be feasible in all surgical indications, observational studies were evaluated in addition to randomized controlled trials (RCTs). 15 Studies were eligible if treatment-specific outcomes were reported in 2 distinct study arms where patients with a single primary degenerative indication underwent lumbar fusion (irrespective of technique), decompression-alone, or nonoperative care. Inclusion required at least 1 measure of safety or efficacy reported at 12 months or greater follow-up. Studies with less than 10 participants per treatment arm were excluded. 16 Multiple publications of a common cohort were included if additional outcomes of interest were reported.
Data Collection
Outcomes included (i) improvement of disease-specific disability as measured by the Oswestry Disability Index; 17 (ii) relief of pain on the visual analog scale (VAS) for low back pain (LBP) or leg pain; 18 (iii) patient-reported satisfaction with treatment outcome; 19 (iv) reoperative rates; (v) all-cause mortality; (vi) treatment-related complications; and (vii) incidence of pseudarthrosis (collected data detailed in Table, Supplemental Digital Content 2) . The methodologic quality of included studies was graded according to 11 criteria proposed by the Cochrane Collaboration Back Review Group (see Table for description of criteria, Supplemental Digital Content 3). 12 Data on treatmentrelated expenses was not collected due to inconsistent methods of estimating costs. Two reviewers independently extracted data in duplicate using a standard data collection form with disagreement resolved through consensus.
Statistical Analysis
Individual estimates of treatment effects were pooled through DerSimonian and Laird random effects models due to expected methodologic variability. 20 Comparisons of continuous outcomes were expressed as weighted mean differences (WMDs) and 95% confidence intervals (CIs). Relative risk (RR), odds ratios (ORs), and 95% CIs were used to assess binary outcomes. Studies contributing to pooled estimates were weighted according to their sample size at the time of outcome assessment and reported measures of dispersion. 20 A continuity correction of 0.5 was applied to rare events. 21 Between-study heterogeneity was assessed using the I 2 test. 22 In the absence of an interaction between study design and adverse events, outcomes were aggregated. The influence of aggregate study characteristics on statistically significant (P < .05) heterogeneity was evaluated through metaregression. The proportion of observed heterogeneity explained by covariates was expressed as the adjusted-R 2 statistic. 23 Publication bias was assessed in each comparison via Egger precision-weighted linear regression and reported only when present.
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RESULTS
Of the 9656 unique citations yielded by the search strategy, 268 full-text articles were subsequently assessed for eligibility ( Figure 1) . A total of 70 publications describing 65 individual studies met all eligibility criteria.
Study Characteristics
The characteristics of the 19 RCTs, 16 prospective cohort studies, 15 retrospective cohort studies, and 15 registry studies that met all eligibility criteria are presented in Tables, Supplemental Digital Content 4 and 5. Included studies reported outcomes in a total of 302 620 adult patients. Among studies that reported explicit selection criteria for fusion, the majority required at least 6 months of failed nonoperative care, and cross-sectional imaging findings commensurate with symptoms (Table) .
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Risk of Bias Assessment
The overall methodologic quality of included studies was low with the majority scoring 4 or less on an 11-point scale (range 1-8; Figure 2 ). 12 Blinded outcome assessment was rarely performed and therefore patient-reported outcomes were potentially biased in favor of interventions preferred by participants or outcome assessors. 33, 34, 66, 67 Other pertinent sources of systemic error identified were related to performance and allocation biases. Performance bias refers to the failure to provide comparable care beyond the intervention under investigation while allocation bias results from an imbalance in prognostic factors between study groups. 68 The limited overall quality of the included studies reflected the predominance of observational designs and the paucity of high-quality RCTs. Stratification by design and metaregression for quality was performed to identify and mitigate allocation and performance biases in each pooled estimate. 
Disability
Seven studies involving 1463 patients reported disability as measured by the Oswestry Disability Index following fusion or nonoperative care ( Figure 3) . 33, 34, [36] [37] [38] 47, 50, 60, 69, 70 Fusion was superior to nonoperative care in the treatment of disability associated with chronic LBP (WMD 5.13, 95% CI 0.19-10.07) and spondylolisthesis (WMD 16.68, 95% CI 14.14-19.22). 33, 34, [36] [37] [38] 47, 50, 60, 69, 70 The moderate degree of heterogeneity present between studies of patients treated for chronic LBP (I 2 = 66.4%, P < .02) was not explained by methodologic quality (P = .15).
Three RCTs enrolling 887 patients reported Oswestry Disability Index scores following decompression or nonoperative care for spinal stenosis (Figure, Supplemental Digital Content 6). 50, 66, 71 Despite over half of all nonoperative patients crossing over to surgery, decompression significantly improved disability when the outcomes of preplanned intention-to-treat analyses were aggregated (WMD 4.21, 95% CI 1.76-6.65). 50, 66, 71 As expected, the benefit of decompression on patients' disability was even greater when only the outcomes of as-treated analyses were considered (WMD 10.78, 95% CI 8.10-13.45). 50, 71 Disability following fusion or decompression-alone was compared in 14 studies involving 10 907 patients (Figure, Supplemental Digital Content 7). 25, 31, 39, 45, 46, 60, 61, 64, 65 Recovery from disability did not significantly differ between fusion or decompression-alone for spinal stenosis in observational studies (WMD 3.71, 95% CI -1.38-8.80) or in a single RCT (WMD 3.00, 95% CI -3.37-9.37). 25, 39, 45, 60, 64 The high degree of heterogeneity between observational studies in patients with spinal stenosis (I 2 = 89.4%, P < .001) was entirely attributable to varying duration of follow-up and years of recruitment (adjusted-R 2 100.0%, P < .02 via multivariate metaregression). Improvement in disability also did not significantly differ in patients undergoing fusion or decompression-alone for spondylolisthesis in summary estimates based on observational studies (WMD 0. 94 
Back Pain
Eight studies compared VAS LBP scores following fusion or nonoperative care ( Figure 4) . 33 73, 74 However, when the same indications were evaluated through similarly sized RCTs, no significant difference in relief from LBP was found between decompression or nonoperative care in patients with disc herniation (WMD 0.57, 95% CI -0.30-1.45) and spinal stenosis (WMD 1.84, 95% CI -0.07-3.75). 50, 72 Thirteen studies reported VAS LBP scores in 14 922 patients after fusion or decompression-alone ( Figure, Supplemental  Digital Content 8) . 25, 39, 45, 54, 61, [63] [64] [65] 75, 76 Fusion resulted in greater improvement in LBP among patients treated for spinal stenosis in pooled estimates derived from observational studies (WMD 0.30, 95% CI 0.01-0.59) but not RCTs (WMD -0.07, 95% CI -1.82-1.69). 25, 30, 39, 45, 64, 76 In the setting of spondylolisthesis, fusion was also superior to decompression-alone in the treatment of LBP in observational studies (WMD 0.42, 95% CI 0.00-0.83) but not in an RCT (WMD 0.10, 95% CI -1.86-2.06). 25, 54, 64, 75 Based on the collective results of 2 observational studies, there was no advantage of fusion relative to decompression-alone in terms of LBP in patients with disc herniation (WMD 1.52, 95% CI -0.73-3.77).
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Leg Pain
Relative to nonoperative care, fusion resulted in a small but significant improvement in leg pain when the results of 3 RCTs enrolling 418 patients with chronic LBP were pooled (WMD 0.77, 95% CI 0.09-1.45; Figure, Supplemental DigitalContent 9). 33, 34, 37 The benefit of fusion over nonoperative care on subsequent leg pain was greater in an RCT conducted in patients with spondylolisthesis (WMD 3.45, 95% CI 0. 16-6.74) . 50 In contrast to fusion, in small RCTs subject to high rates of crossover to surgery, decompression-alone did not significantly differ from nonoperative care in the treatment of leg pain associated with spinal stenosis (WMD 1.25, 95% CI -0.56-3.06; Figure, Supplemental Digital Content 10) or disc herniation (WMD 0.26, 95% CI -0.90-1.42). 50, 72 In pooled estimates of 12 studies reporting on 14 877 patients, VAS leg pain scores were similar following either fusion or decompression-alone ( Figure 5) . 25, 39, 45, 54, 61, 63, 64, 75, 76 There was no difference between the 2 interventions in summary estimates from observational studies in patients treated for spinal stenosis (WMD 0.39, 95% CI -0.26-1.05), spondylolisthesis (WMD 0.33, 95% CI -0.12-0.79), or disc herniation (WMD -0.14, 95% CI -1.59-1.31). 25, 39, 45, 54, 61, 63, 75, 76 The moderate degree of heterogeneity (I 2 = 70.0%, P < .01) present in the pooled estimate for leg pain in patients after fusion or decompressionalone for spinal stenosis was explained by the duration of followup with differences in leg pain decreasing with longer follow-up (adjusted-R 2 100%, P < .04).
Satisfaction
Six RCTs and a retrospective cohort study reported satisfaction in 1610 patients following fusion or nonoperative care ( Figure 6) . 33, 34, 37, 38, 47, 56, 77 Summary estimates of the odds of patients being satisfied with their care were increased 4-fold after fusion for spondylolisthesis as opposed to nonoperative care (OR 4.02, 95% CI 2.66-6.06). 47, 56 When performed for chronic LBP, fusion doubled the odds of satisfaction in RCTs (OR 2.14, 95% CI 1.06-4.34). 33, 34, 37, 38 Similarly, a retrospective study reported an increased odds of satisfaction following fusion instead of nonoperative care for degenerative disc disease (OR 4.47, 95% CI 1.20-16.71). 77 The advantage of surgical intervention in achieving patient satisfaction was also apparent in the 5 RCTs and 3 observational studies reporting satisfaction in 1501 patients following decompression or nonoperative care ( Figure, Supplemental  Digital Content 11) . 66, 71, [78] [79] [80] [81] Decompression for spinal stenosis increased the odds of patient satisfaction relative to nonoperative care in the intention-to-treat analyses of RCTs where over half of patients crossed over to surgery (OR 1.55, 95% CI 1.01-2.39). 66, 71, 78 The benefit associated with decompression for spinal stenosis was greater in observational studies (OR 2.13, 95% CI 1.49-3.03). 71, 78, 79 In the setting of degenerative disc disease, a single RCT enrolling 126 patients observed no improvement satisfaction following
FIGURE 5. Leg pain following fusion or decompression-alone. WMD estimates difference in improvement on baseline between treatment groups. The intensity of pain was measured by a horizontal 10-cm VAS, with 0 representing no pain and 10 the worst pain ever experienced. Quality was measured on an 11-point scale with higher scores indicating increasing methodologic quality. BP-back pain; CI-confidence intervals; LP-leg pain; mth-months; prosp-prospective; retro-retrospective; RCT-randomized controlled trial.
decompression as opposed to nonoperative care (OR 2.43, 95% CI 0.76-7.81). 81 Patient satisfaction did not significantly differ between fusion or decompression-alone in any surgical indication evaluated by 14 studies of 6015 patients ( Figure, Supplemental Digital  Content 12) . 30 
Mortality
Mortality and treatment modality were not associated in any pooled outcome of 20 studies reporting mortality in 16 199 patients following fusion, decompression-alone, or nonoperative care. 29, 32, 34, 37, 43, 45, 47, 52, 56, 61, 65, 66, 71, 78, 80, 83, 84 No statistically significant differences in the risk of death were reported following fusion or nonoperative care for chronic LBP (RR 3.08, 95% CI 0.37-25.31; Figure 7 ), degenerative scoliosis (RR 0.38, 95% CI 0.02-8.89), or spondylolisthesis (RR 0.51, 95% CI 0.16-1.57). 32, 34, 37, 43, 47, 52, 56 The risk of death similarly did not differ following decompression or nonoperative care in a summary estimate derived from 6 studies, all of which enrolled patients with spinal stenosis (RR 0.85, 95% CI 0.41-1.80; Figure, Supplemental Digital Content 13). 66, 71, 78, 80 Despite differing designs, the variance between individual studies was minimal (I 2 = 0.0%, P = .71).
When fusion was compared to decompression-alone, there was no significant difference in the risk of death in patients treated for spondylolisthesis (RR 0.14, 95% CI 0.01-2.64; Figure, Supplemental Digital Content 14) or spinal stenosis (RR 0.65, 95% CI 0.33-1.29; I 2 = 75.4%, P < .02). 29, 45, 65, 84, 85 While there were insufficient observations to permit metaregression, sensitivity analysis revealed that the heterogeneity present in the pooled estimate of mortality in patients treated for spinal stenosis was attributable to a single study conducted by Kim et al. 84 Authors of the retrospective study observed that 10-year survival was significantly reduced in patients undergoing decompression-alone. The association, however, was no longer present after adjustment for patients' age and gender suggesting an allocation bias in the original estimate.
Reoperation
Thirty-five studies reported reoperative outcomes in a total of 266 939 patients who underwent fusion or decompression-alone ( Figure, Supplemental Digital Content  15) . 25, 26, [29] [30] [31] 35, 40, [42] [43] [44] [45] [46] 48, 49, 53, 57, 58, 61, 62, 64, 65, 75, 76, [84] [85] [86] [87] Fusion performed for spinal stenosis increased the risk of reoperation relative to decompression-alone in a comparison involving 159 378 patients (RR 1.17, 95% CI 1.06-1.28; I 2 = 49.3%, P < .02; Figure 8) . 25, 29, 30, 35, 40, 42, 45, 49, 53, 57, 64, 76, 85, 87, 88 The moderate degree of heterogeneity between the 15 studies reporting reoperative risk in patients treated for spinal stenosis was attributed in part to varying duration of follow-up with the excess risk resulting from fusion decreased in studies with longer followup (adjusted-R 2 7.0%, P < .05). Reoperative rates were also increased following fusion for disc herniation (RR 1.29, 95% CI 1.09-1.51) and degenerative scoliosis (RR 7.62, 95% CI 2.33-24.87). 31, 43, 49 In contrast, fusion for spondylolisthesis reduced the risk of reoperation compared to decompression-alone based on the outcomes of 63 140 patients (RR 0.75, 95% CI 0.68-0.83; Figure 9 ). [25] [26] [27] 44, 48, 53, 58, 64, 65, 86 
Complications
Treatment-related complications following fusion or decompression-alone were reported in 14 studies involving 7665 patients ( Figure 10) . 30, 31, 41, 54, 58, 59, 61, [63] [64] [65] 76, 87, 89 Variance between studies was not dependent on study design (P = .47). Based predominantly on the outcomes of observational studies, fusion increased the risk of complications in patients treated for spinal stenosis (RR 1.87, 95% CI 1.18-2.96). 30, 64, 76, 87 Complications were also more frequent after fusion for degenerative scoliosis in a single observational study (RR 5.33, 95% CI 1. 43-19.84) . 31 Among patients with spondylolisthesis, however, there was no significant difference in the risk of complications between fusion and decompression-alone (RR 1.43, 95% CI 0.60-3.39). 54, 58, 65, 89 
FIGURE 7. Risk of death following fusion or nonoperative care. Quality was measured on an 11-point scale with higher scores indicating increasing methodologic quality. †-relative risk could not be estimated due to 0 total events reported in both study arms. CI-confidence intervals; mth-month; prosp-prospective; retroretrospective; RCT-randomized controlled trial.
The incidence of pseudarthrosis was consistently defined as the failure to achieve bridging bone across adjacent vertebra on radiological imaging following attempted fusion, and therefore 20 estimates based on 14 868 patients who underwent fusion were pooled (Figure, Supplemental Digital Content 16; see Supplemental Digital Content 17 for a list of references used in all other Supplemental Digital Content). 26, 30, 31, 33, 34, 42, 43, [47] [48] [49] [52] [53] [54] [55] [56] 59, 61, [63] [64] [65] Variance in estimates of pseudarthrosis was attributed to the wide-ranging duration of follow-up and varying surgical indications (adjusted-R 2 44.0%, P < .05 via multivariate metaregression). The incidence of pseudarthrosis increased with longer follow-up and when fusion was performed for spondylolisthesis (8 
DISCUSSION
The conclusions of previous reviews of lumbar fusion for degenerative indications have been limited by their dependence on the outcomes of few RCTs. [90] [91] [92] [93] Further, the high rates of crossover to surgery of recent trials suggest that random assignment to nonoperative care may not be feasible for all indications. 47, 66, 71, 72 Despite the absence of the highest level of evidence, the best possible care must still be provided. Observational data may therefore supplement the results of RCTs by providing estimates of treatment effects that better reflect clinical outcomes achieved in practice. In addition, the often broadly inclusive eligibility criteria of observational studies help to ensure the generalizability of their results. 94, 95 When combined with the quantitative evaluation for bias, conclusions incorporating both randomized and observational evidence may enable clinicians to provide care that best addresses patient-specific goals.
Evidence in support of lumbar fusion was most compelling for the primary indication of spondylolisthesis. Patients randomly assigned to fusion as opposed to nonoperative care were 4 times as likely to be satisfied and attained 34% greater relief of initial LBP. Fusion for spondylolisthesis also achieved a 40% improvement of preoperative disability relative to nonoperative care, a difference that exceeded the definition of a substantial clinical benefit. 96, 97 While observational studies directly comparing fusion with decompression for spondylolisthesis demonstrated a modest improvement in LBP following fusion, reoperative risk was reduced considerably with fusion resulting in 25% less risk of requiring revision surgery.
Summary outcome measures suggested a limited role for fusion in the management of spinal stenosis without spondylolisthesis. Randomized comparisons demonstrated both fusion and decompression-alone resulted in an improvement in disability that exceeded consensus values for a minimal clinically important difference. 96 Similarly, in both randomized and observational studies, the 2 interventions did not discernibly differ in the odds of satisfaction or improvement in leg pain. While in large observational studies fusion for spinal stenosis provided slightly greater relief of LBP than decompression-alone, the additional benefit represented only 5% of preoperative LBP and was not evident in randomized comparisons. This modest potential benefit, however, was achieved at the expense of greater harm as fusion for spinal stenosis resulted in a 17% increase in reoperative risk and nearly twice the risk of complications relative to decompressionalone.
Fusion provided greater pain relief than nonoperative care in patients suffering from chronic LBP in the absence of spinal stenosis or spondylolisthesis. The magnitude of the associated benefits, however, should be weighed against the risks of treatment-related adverse events. 96, 98 The collective results of 5 RCTs reported fusion as opposed to nonoperative care resulted in 16% and 18% greater improvement in preoperative low back and leg pain, respectively. 33, 34, [36] [37] [38] While fusion doubled the odds of patient satisfaction, cases were complicated by a pseudarthrosis rate of approximately 13%. Disability outcomes after fusion for chronic LBP were less clear, however, due to significant heterogeneity between trials that was not associated with study characteristics.
Several features may limit the generalizability of this review. First, patients who previously underwent lumbar spine surgery were frequently excluded from studies. The results of this review are therefore not applicable in patients undergoing revision lumbar spine surgery. Second, the high rates of crossover to surgery often biased intention-to-treat analyses toward the null hypothesis and subjected as-treated analyses to allocation bias. As a result, the findings of trials with high crossover rates were difficult to interpret or unexpected such as the failure of decompression for spinal stenosis to provide significantly greater relief of leg pain relative to nonoperative care. Finally, individual studies varied in their diagnostic criteria, patient selection, and surgical technique, contributing to between-study heterogeneity that could not be accounted for. Summary estimates reliant on registry data were most likely to be affected by the variable classification of patients and outcomes; however, both surgical interventions were assumed to be affected in the same way.
CONCLUSION
The benefits of fusion varied according to surgical indications, study methodology, and clinical domains. Improvements in pain, disability, and satisfaction were greatest in patients undergoing fusion for spondylolisthesis. Complications and reoperative risk limited the role of fusion for spinal stenosis without spondylolisthesis. The magnitude of the expected benefits and potential treatment-related adverse events following fusion for chronic LBP suggested careful patient selection is required. Given the patient cohort-and study design-dependent benefits of fusion, future efforts should seek to guide clinical decision making by identifying specific predictors of positive outcomes. in the meta-analysis represent truly different populations. This limitation is somewhat mitigated by the large number of studies and patients included in the analysis, and is a limitation present in all such metaanalytic studies. The methodology appears consistent and in accordance with the Cochrane Review group, with appropriate rating of the quality of the included studies and determination of potential sources of bias.
Overall, the authors have completed an exhaustive review of the literature for lumbar fusion and are to be commended for further defining the role of lumbar fusion in management of degenerative spinal disorders.
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